Valeant Keeps Door Open For Consumer Products Acquisitions
This article was originally published in The Tan Sheet
Executive Summary
The specialty pharmaceutical firm’s consumer products portfolio has grown with the closing of its ophthalmology firm Bausch & Lomb acquisition. Valeant is not ruling out more acquisitions in the consumer products space, CEO J. Michael Pearson says.